The role of axillary lymph node dissection in breast cancer management

Breast Cancer

Volumn 4, Issue 3, 1997, Pages 143-153

  Noguchi, Masakuni ^a   Miwa, Koichi ^a   Michigishi, Takatoshi ^a   Yokoyama, Kunihiko ^a   Nishijima, Hiroshi ^a   Takanaka, Tsuyoshi ^a   Kawashima, Hiroko ^a   Nakamura, Shinobu ^a   Kanno, Hiroshi ^a   Nonomura, Akitaka ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Axillary dissection; Axillary metastases; Breast cancer; Sentinel lymph node biopsy

Indexed keywords

EID: 0000646693     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967068     Document Type: Review

References (98)

1. Senofsky GM, Moffat FL Jr, Davis K, et al: Total axillary lymphadenectomy in the management of breast cancer. Arch Surg 126:32-1342, 1991.
2. Moffat FL Jr, Senofsky GM, Cavis K, et al: Axillary node dissection for early breast cancer; Some is good, but all is better. J Surg Oncol 51:32-13, 1992.
3. Fisher B, Redmond C, Fisher ER, et al: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312:32-681, 1985.
4. Donegan WL: Surgical clinical trials. Cancer 53:32-699, 1984.
5. Harris JR, Osteen RT: Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 5:32-21, 1985.
6. Gardner B, Feldman J: Are positive axillary nodes in breast cancer markers for incurable disease? Ann Surg 218:32-278, 1993.
7. Morrow M: Role of axillary dissection in breast cancer management. Ann Surg Oncol 3:32-234, 1996.
8. Noguchi M, Kinne DW, Miyazaki I: Controversies in the surgical management of operable breast cancer. Breast Cancer 1:32-88, 1994.
9. Fentiman IS, Mansel RE: The axilla; Not a no-go zone. Lancet 337:32-223, 1991.
10. Wazer DE, Erban JK, Robert NJ, et al: Breast conservation in elderly women for clinically negative axillary lymph nodes without axillary dissection. Cancer 74:32-883, 1994.
11. Feigelson BJ, Acosta JA, Feigelson HS, et al: T1 breast carcinoma in women 70 years of age and older may not require axillary lymph node dissection. Am J Surg 172:32-490, 1996.
12. Silverstein MJ, Gierson ED, Waisman JR, et al: Axillary lymph node dissection for T1a breast carcinoma; Is it indicated? Cancer 73:32-667, 1994.
13. Cady B, Stone MD, Wayne J: New therapeutic possibilities in primary invasive breast cancer. Ann Surg 218:32-349, 1993.
14. Chadha M, Chabon AB, Friedmann P, et al: Predictors of axillary lymph node metastases in patients with Tl breast cancer. Cancer 73:32-353, 1994.
15. Greco M, Agresti R, Raselli R, et al: Axillary dissection can be avoided in selected breast cancer patients; Analysis of 401 cases. Anticancer Res 16:32-3918, 1996.
16. McGee JM, Youmans R, Clingan F, et al: The value of axillary dissection in Tla breast cancer. Am J Surg 172:32-505, 1996.
17. White RE, Vezeridis MP, Konstadoulakis M, et al: Therapeutic options and results for the management of minimally invasive carcinoma of the breast; Influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg 183:32-582, 1996.
18. Haffty BG, McKhann C, Beinfield M, et al: Breast conservation therapy without axillary dissection. Arch Surg 128:32-1319, 1993.
19. Dewar JA, Sarrazin D, Benhamou E, et al: Management of the axilla in conservatively treated breast cancer; 592 patients treated at Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys 13:32-481, 1987.
20. Ogawa Y, Nishioka A, Hamada N, et al: Significance of axillary node dissection for patients with breast cancer. Jpn J Breast Cancer 10:32-478, 1995 (in Japanese with English summary).
21. Lythgoe JP, Palmer MK: Manchester regional breast study; 5 and 10 year results. Br J Surg 69:32-696, 1982.
22. Cancer Research Campaign Working Party: Cancer research campaign (King's/Cambridge) trial for early breast cancer; A detailed update at the tenth year. Lancet 2:32-60, 1980.
23. Ribeiro GG, Magee B, Swindell R, et al: The Christie Hospital breast conservation trial; An update at 8 years from inception. Clin Oncol 5:32-283, 1993.
24. Langlands AO, Prescott RJ, Hamilton T: A clinical trial in the management of operable cancer of the breast. Br J Surg 67:32-174, 1980.
25. Hayward JL: The Guy's Hospital trials on breast conservation. In: Harris JR, Hellman S, Silen W eds, Conservative Management of Breast Cancer, J. B. Lippincott, Philadelphia, pp77-90, 1983.
26. Hayward J, Caleffi M: The significance of local control in the primary treatment of breast cancer. Arch Surg 122:32-1247, 1987.
27. Hayward JL: The Guy's trial of treatments of "early" breast cancer. World J Surg 1:32-316, 1977.
28. Cabanes PA, Salmon RJ, Vilcoq JR, et al: Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 339:32-1248, 1992.
29. Early Breast Cancer Trialists' Collaborative Group: Effects of radiotherapy and surgery in early breast cancer; An overview of the randomized trials. N Engl J Med 333:32-1455, 1995.
30. Dent DM: Axillary lymphadenectomy for breast cancer; Paradigm shifts and pragmatic surgeons. Arch Surg 131:32-1127, 1996.
31. Adair F, Berg J, Joubert L, et al: Long-term followup of breast cancer patients; The 30-year report. Cancer 33:32-1150, 1974.
32. Danforth DN: The role of axillary lymphnode dissection in the management of breast cancer. Principles Practice Oncol 6:32-16, 1992.
33. Fisher B, Bauer M, Wickerham L, et al: Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer; An NSABP update. Cancer 52:32-1557, 1983.
34. Smith JA III, Gamez-Araujo JJ, Gallager HS, et al: Carcinoma of the breast; Analysis of total lymph node involvement versus level of metastases. Cancer 39:32-532, 1977.
35. Miura S: The prognostic significance of axillary node metastases in breast cancer. Jpn J Breast Cancer 10:32-459, 1995 (in Japanese with English summary).
36. Cascinelli N, Greco M, Bufalino R, et al: Prognosis of breast cancer with axillary node metastases after surgical treatment only. Eur J Cancer Clin Oncol 23:32-799, 1987.
37. Steele R J C, Forrest A P M, Gibson T, et al: The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer; A controlled randomized trial. Br J Surg 72:32-369, 1985.
38. Forrest A P M, Stewart HJ, Roberts MM, et al: Simple mastectomy and axillary node sampling (pectoral node biopsy) in the management of primary breast cancer. Ann Surg 196:32-378, 1982.
39. Davies GC, Millis RR, Hayward JL: Assessment of axillary lymph nodes status. Ann Surg 192:32-151, 1980.
40. Noguchi M, Minami M, Earashi M, et al: Intraoperative assessment of axillary lymph node metastases in operable breast cancer. Breast Cancer Res Treat 40:32-185, 1996.
41. Kissin MW, Price AB, Thompson EM, et al: The inadequacy of axillary sampling in breast cancer. Lancet i: 1210-1212, 1982.
42. Axelsson CK, Mouridsen HT, Zedeler K: Axillary dissection of level I and II lymph nodes is important in breast cancer classification. Eur J Cancer 28 A: 1415-1418, 1992.
43. Mathiesen O, Carl J, Bonderup O, et al: Axillary sampling and the risk of erroneous staging of breast cancer; An analysis of 960 consecutive patients. Acta Oncol 29:32-725, 1990.
44. Kiricuta CI, Tausch J: A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer 69:32-2501, 1992.
45. Siegel BM, Mayzel KA, Love SM: Level I and II axillary dissection in the treatment of early-stage breast cancer; An analysis of 259 consecutive patients. Arch Surg 125:32-1147, 1990.
46. Consensus Conference: Adjuvant chemotherapy for breast cancer. JAMA 254:32-3463, 1985.
47. Early breast cancer trialists' collaborative group: Systemic treatment of early breast cancer by hormonal cytotoxic or immune therapy. Lancet 339:32-15, 71-85, 1992.
48. National Cancer Institute: Clinical alert from the National Cancer Institute. Breast Cancer Res Treat 12:32-5, 1988.
49. McGuire WL: Adjuvant therapy of node-negative breast cancer. N Engl J Med 320:32-527, 1989.
50. Mansour EG, Gray R, Shatila AH, et al: Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. N Engl J Med 320:32-490, 1989.
51. Haffty BG, Fischer D, Rose M, et al: Prognostic factors for local recurrence in the conservatively treated breast cancer patients; A cautious interpretation of the data. J Clin Oncol 9:32-1003, 1991.
52. Haffty BG, Ward B, Pathare P, et al: Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer. J Clin Oncol 15:32-700, 1997.
53. Noguchi M, Miyazaki I: Prognostic factors in breast cancer and their controversies (Review). Oncology Report 1:32-1163, 1994.
54. Balch CM, Singletary SE, Bland KI: Clinical decisionmaking in early breast cancer. Ann Surg 217:32-225, 1993.
55. Forrest A P M, Roberts MM, Preece P, et al: The Cardiff-St. Mary's trial. Br J Surg 61:32-769, 1974.
56. Fisher B, Montague E, Redmond C, et al: Comparison of radical mastectomy with alternative treatments for primary breast cancer. Cancer 39:32-2839, 1977.
57. Fisher B, Wolmark N, Bauer M, et al: The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 152:32-772, 1981.
58. Hamilton T, Langlands AO, Prescott RJ: The treatment of operable cancer of the breast; A clinical trial in the South-East Region of Scotland. Br J Surg 61:32-761, 1974.
59. Graversen HP, Blichert-Toft M, Andersen JA, et al: Breat cancer risk of axillary recurrence in nodenegative patients following partial dissection of the axilla. Eur J Surg Oncol 14:32-412, 1988.
60. Benson EA, Thorogood J: The effect of surgical technique on local recurrence rates following mastectomy. Eur J Surg Oncol 12:32-271, 1986.
61. Larson D, Weinstein M, Goldberg I, et al: Edema of the arm as a function of the extent of axillary surgery in patients with stage I - II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Biol Phys 12:32-1582, 1986.
62. Beadle GF, Silver B, Botnick L, et al: Cosmetic results following primary radiation therapy for early breast cancer. Cancer 54:32-2918, 1984.
63. Rosen PP, Lesser MT, Kinne DW, et al: Discontinuous or "skip" metastases in breast carcinoma; Analysis of 1228 axillary dissection. Ann Surg 197:32-283, 1983.
64. Veronesi U, Rilke F, Luini A, et al: Distribution of axillary node metastases by level of invasion; An analysis of 539 cases. Cancer 59:32-687, 1987.
65. Noguchi M, Taniya T, de Aretxabala X, et al: The significance of regional lymph node dissection in the surgical management of breast cancer. Jpn J Surg 19:32-28, 1989.
66. Kinne DW: Controversies in primary breast cancer management. Am J Surg 166:32-508, 1993.
67. Schwartz GF, D'Ugo DM, Rosenberg AL: Extent of axillary dissection preceding irradiation for carcinoma of the breast. Arch Surg 121:32-1398, 1986.
68. Delouche G, Bachelot F, Premont M, et al: Conservation treatment of early breast cancer; Long term results and complications. Int J Radiat Oncol Biol Phys 13:32-34, 1987.
69. Osborne MP, Ormiston N, Harmer CL, et al: Breast conservation in the treatment of early breast cancer; A 20-year follow-up. Cancer 53:32-355, 1984.
70. Recht PP, Connolly JL, Schnitt SJ, et al: Conservative surgery and radiation therapy for early breast cancer; Results, controversies, and unsolved problems. Semin Oncol 13:32-449, 1986.
71. Kissin MW, Querci della Rovere G, Easton D, et al: Risk of lymphoedema following the treatment of breast cancer. Br J Surg 73:32-584, 1986.
72. Fisher B, Wolmark N: Conservative surgery; The American experience. Semin Oncol 13:32-433, 1986.
73. Recht A, Pierce SM, Abner A, et al: Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 9:32-996, 1991.
74. Brismar B, Ljungdahl I: Postoperative lymphoedema after treatment of breast cancer. Acta Chir Scand 149:32-689, 1983.
75. Ivens D, Hoe AL, Podd TJ, et al: Assessment of morbidity from complete axillary dissection. Br J Cancer 66:32-138, 1992.
76. Bryant M, Baum M: Postoperative seroma following mastectomy and axillary dissection. Br J Surg 74:32, 1987.
77. Carabell SC, Richter MP, Bryan JH, et al: Radiation therapy as an alternative to mastectomy for breast cancer; The role of axillary sampling. Int J Radiat Oncol Biol Phys 7:32-32, 1981.
78. Veronesi U, Saccozzi R, Del Vecchio M, et al: Comparing radical mastectomy with quadrantectomy, axillary dissection and radiotherapy in patients with small cancers of the breast. N Engl J Med 305:32-11, 1981.
79. Chetty V, Forrest A P M: Breast conservation. Br J Surg 73:32-600, 1986.
80. Veronesi U, Ballfi A, Salvadori B, et al: Breast conservation is the treatment of choice breast cancer; Long-term results of randomized trial. Eur J Cancer 26:32-670, 1990.
81. Silverstein MJ, Rosser RJ, Gierson ED, et al: Axillary lymph node dissection for intraductal breast carcinoma; Is it indicated? Cancer 59:32-1824, 1987.
82. Lagios MD, Westdahl PR, Margolin FR, et al: Duct carcinoma in situ; Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 50:32-1314, 1977.
83. Carter D, Smith RL: Carcinoma in situ of the breast. Cancer 40:32-1193, 1977.
84. Noguchi M, Katev N, Miyazaki I: Diagnosis of axillary lymph node metastases in patients with breast cancer. Breast Cancer Res Treat 40:32-293, 1996.
85. Whitten TM, Fraser HR, Christensen WN, et al: Axillary lymph node metastasis in stage T1a breast cancer; A pathologic review of 82 patients. Am Surg 63:32-149, 1997.
86. Cady B: The need of reexamine axillary lymph node dissection in invasive breast cancer. Cancer 73:32-508, 1994.
87. Rosen PP, Groshen S, Saigo PE, et al: Pathological prognostic factors in stage (T1N0M0) and stage II (T1N1M0) breast carcinomas; A study of 644 patients with median follow-up of 18 years. J Clin Oncol 7:32-1251, 1989.
88. Mustafa IA, Cole B, Wanebo HJ, et al: The impact of histopathology on nodal metastases in minimal breast cancer. Arch Surg 132:32-391, 1997.
89. Copeland EM: Is axillary dissection necessary for T1 carcinoma of the breast? J Am Coll Surg 184:32-398, 1997.
90. Naslund E, Fernstad R, Ekman S, et al: Breast cancer in women over 75 years: Is axillary dissection always necessary? Eur J Surg 162:32-871, 1996.
91. Amsterdam E, Birkenfeld S, Gilad A, et al: Surgery for carcinoma of the breast in women over 70 years of age. J Surg Oncol 35:32-183, 1987.
92. Fisher CJ, Egan MK, Smith P, et al: Histopathology of breast cancer in relation to age. Br J Cancer 75:32-596, 1997.
93. Giuliano AE, Kirgan DM, Guenther JM, et al: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:32-401, 1994.
94. Giuliano AE, Dale PS, Turner RR, et al: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222:32-401, 1995.
95. Giuliano AE, Barth AM, Spivack B, et al: Incidence and predictors of axillary metastasis in T1 carcinoma of the breast. J Am Coll Surg 183:32-189, 1996.
96. Noguchi M: Comment on "Improved axillary staging of breast cancer with sentinel lymphadenectomy". Ann Surg 225:32-127, 1997.
97. Albertini J J, Lyman GH, Cox C, et al: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:32-1822, 1996.
98. Bland KI: Enhancing the accuracy for predictors of axillary nodal metastasis in T1 carcinoma of the breast; Role of selective biopsy with lymphatic mapping. J Am Coll Surg 183:32-264, 1996.